BillionToOne SVP ten Bosch John Roderick sold 1,416 shares at $97.54 per share. The transaction represented about 5.4% of his prior holding, leaving him with 25,051 shares after the sale, according to the reported ownership figures.
Key Highlights
- Ten Bosch John Roderick held 25,051 BillionToOne shares after the transaction.
- The transaction represented about 5.4% of his prior share holding.
- The sale carried transaction code S and occurred on September 9, 2026.
BillionToOne, Inc. (NASDAQ: BLLN) executive ten Bosch John Roderick sold 1,416 shares at $97.54 per share. The transaction involved the company’s SVP of Laboratory Operations and took place on September 9, 2026. Ten Bosch John Roderick is identified as BillionToOne’s SVP of Laboratory Operations. The transaction price was $97.54 per share. The sale represented about 5.4% of his prior share holding.
FAQs
Q: How many BillionToOne shares did ten Bosch John Roderick sell?
A: BillionToOne SVP ten Bosch John Roderick sold 1,416 shares at $97.54 per share. The transaction took place on September 9, 2026.
Q: What was the impact of the BillionToOne insider sale?
A: The reported transaction left ten Bosch John Roderick with 25,051 BillionToOne shares. The sale represented about 5.4% of his prior holding.
Q: What does transaction code S mean for BLLN stock?
A: In this case, transaction code S applied to ten Bosch John Roderick’s sale of 1,416 BillionToOne shares. The transaction price was $97.54 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.